Cat. No. |
Product Name |
Information |
PC-23916 |
AKT1 (E17K) inhibitor compound 4
AKT1 (E17K) inhibitor
|
AKT1 (E17K) inhibitor compound 4 is a potent, mutant-selective inhibitor of AKT1 (E17K) mutant, potently reduces cell viability of LAPC4-CR cells with EC50 of 9 nM. |
PC-23915 |
AKT1 (E17K) inhibitor compound 3
AKT1 (E17K) inhibitor
|
AKT1 (E17K) inhibitor compound 3 is a potent, mutant-selective inhibitor of AKT1 (E17K) mutant, potently reduces cell viability of LAPC4-CR cells with EC50 of 20 nM. |
PC-23340 |
Triciribine
Akt inhibitor
|
Triciribine is a purine analog and DNA synthesis inhibitor, also inhibits Akt and HIV-1/2 with IC50 of 130 nM, and 0.02-0.46 μM, respectively, selectively inhibits the phosphorylation and activation of all three Akt isoforms. |
PC-20556 |
AT13148
AGC kinase inhibitor
|
AT13148 (AT 13148) is a potent, ATP-competitive and orally active multi-AGC kinase inhibitor with IC50 vaules of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. |